glp 1 average weekly weight loss GLP-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness The UK's Complete Guide to
Description
The patterns that led to weight gain have been disrupted for long enough that new patterns have taken root

20.8% said they went through a weight loss clinic/program
At 3 months, semaglutide typically produces 6 to 8% weight loss while tirzepatide produces 7 to 10%

With a growing body of research supporting its efficacy, GLP-1 offers hope for those seeking sustainable and effective weight loss solutions

In the Step 1 trial (note: funded by Novo-Nordisk) of 1,961 individuals, the average weight loss at 68 weeks was 14.9% at the maximum dose of 2.4 mg weekly, equating to 15.3 kg (33.6 lbs) lost compared to 2.6 kg (5.7 lbs) in the placebo group
The common narrative reduces these medications to appetite suppressants
